Synergistic role of signaling and epigenetics in leukemic transformation

信号传导和表观遗传学在白血病转化中的协同作用

基本信息

  • 批准号:
    10737736
  • 负责人:
  • 金额:
    $ 106.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-01-17 至 2030-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT ABSTRACT We propose to use single cell studies of clinical isolates to explicate how mutations and differentiation status coordinately regulate cell state, clonal expansion and malignant transformation. We will model sequential activation/inactivation of somatic mutations in defined cell compartments and perform functional studies to uncover critical gene networks and therapeutic dependencies. This will include single cell studies in primary patient samples, use of innovative models which allow for sequential mutational activation/inactivation, and functional genomic approaches to delineate mechanisms of transformation and novel therapeutic dependencies. Moreover, we will delineate crosstalk between different cell types in normal and malignant hematopoiesis and how these interactions impact therapeutic response. These tools will be distributed widely to enable studies of tissue development/homeostasis, cell state changes, transformation, and therapeutic dependencies.
项目摘要 我们建议使用临床分离株的单细胞研究来阐明突变和分化状态如何影响临床分离株的功能。 协调调节细胞状态、克隆扩增和恶性转化。我们将模拟连续的 在确定的细胞区室中激活/失活体细胞突变,并进行功能研究, 揭示关键基因网络和治疗依赖性。这将包括原发性肝癌的单细胞研究。 患者样本,使用允许顺序突变激活/失活的创新模型,以及 功能基因组方法来描绘转化机制和新的治疗依赖性。 此外,我们将描绘正常和恶性造血中不同细胞类型之间的串扰, 这些相互作用如何影响治疗反应。这些工具将广泛分发,以便能够研究 组织发育/稳态、细胞状态变化、转化和治疗依赖性。

项目成果

期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms.
  • DOI:
    10.1016/j.ccell.2017.11.009
  • 发表时间:
    2018-01-08
  • 期刊:
  • 影响因子:
    50.3
  • 作者:
    Kleppe M;Koche R;Zou L;van Galen P;Hill CE;Dong L;De Groote S;Papalexi E;Hanasoge Somasundara AV;Cordner K;Keller M;Farnoud N;Medina J;McGovern E;Reyes J;Roberts J;Witkin M;Rapaport F;Teruya-Feldstein J;Qi J;Rampal R;Bernstein BE;Bradner JE;Levine RL
  • 通讯作者:
    Levine RL
Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia.
  • DOI:
    10.1158/2159-8290.cd-16-1049
  • 发表时间:
    2017-05
  • 期刊:
  • 影响因子:
    28.2
  • 作者:
    Shih AH;Meydan C;Shank K;Garrett-Bakelman FE;Ward PS;Intlekofer AM;Nazir A;Stein EM;Knapp K;Glass J;Travins J;Straley K;Gliser C;Mason CE;Yen K;Thompson CB;Melnick A;Levine RL
  • 通讯作者:
    Levine RL
JAK2S523L, a novel gain-of-function mutation in a critical autoregulatory residue in JAK2V617F- MPNs.
JAK2S523L,JAK2V617F-MPN 中关键自动调节残基的一种新型功能获得性突变。
  • DOI:
    10.1182/bloodadvances.2019001283
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    7.5
  • 作者:
    Pastore,Friederike;Krishnan,Aishwarya;Hammarén,HenrikM;Silvennoinen,Olli;Yan,Benedict;Levine,RossL
  • 通讯作者:
    Levine,RossL
Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib.
  • DOI:
    10.1038/s41591-018-0115-6
  • 发表时间:
    2018-08
  • 期刊:
  • 影响因子:
    82.9
  • 作者:
    Quek L;David MD;Kennedy A;Metzner M;Amatangelo M;Shih A;Stoilova B;Quivoron C;Heiblig M;Willekens C;Saada V;Alsafadi S;Vijayabaskar MS;Peniket A;Bernard OA;Agresta S;Yen K;MacBeth K;Stein E;Vassiliou GS;Levine R;De Botton S;Thakurta A;Penard-Lacronique V;Vyas P
  • 通讯作者:
    Vyas P
Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia.
急性髓系白血病可测量残留疾病的单细胞基因型和表型分析。
  • DOI:
    10.1126/sciadv.adg0488
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    13.6
  • 作者:
    Robinson,TroyM;Bowman,RobertL;Persaud,Sonali;Liu,Ying;Neigenfind,Rosemary;Gao,Qi;Zhang,Jingping;Sun,Xiaotian;Miles,LindeA;Cai,ShengF;Sciambi,Adam;Llanso,Aaron;Famulare,Christopher;Goldberg,Aaron;Dogan,Ahmet;Roshal,Mikhai
  • 通讯作者:
    Roshal,Mikhai
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ross L Levine其他文献

Blood flow reactivity to hypercapnia in strictly unilateral carotid disease: preliminary results.
严格单侧颈动脉疾病中血流对高碳酸血症的反应:初步结果。
  • DOI:
  • 发表时间:
    1991
  • 期刊:
  • 影响因子:
    11
  • 作者:
    Ross L Levine;Jeffrey A Dobkin;JackM Rozental;Martin R Satter;R. J. Nickles;William S Middleton
  • 通讯作者:
    William S Middleton
Crebbp Inhibition Potentiates JAK2 Inhibition in Post-MPN Acute Myeloid Leukemia
  • DOI:
    10.1182/blood-2024-201988
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Kalay Bertulfo;Hannah Miller;Ryan Najac;Juan Carlos Castelan;Cindy Ma;Koen Debackere;Wenbin Xiao;Raajit Rampal;Ross L Levine;Chao Lu;Adolfo A. Ferrando;Teresa Palomero
  • 通讯作者:
    Teresa Palomero
TMPRSS6 Antisense Oligonucleotide Therapy Reverses Inflammation in <em>Jak2</em><sup>V617F</sup> Mutant Mice
  • DOI:
    10.1182/blood-2024-203806
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Maayan Levy;Huihui Li;Andrew Dunbar;Zixing Huang;Young Park;Min Lu;Pinanong Na Phattalung;Marina Planoutene;Carla Casu;Stefano Rivella;Shuling Guo;Ross L Levine;Ronald Hoffman;Yelena Ginzburg
  • 通讯作者:
    Yelena Ginzburg
TET2 and TP53 Mutations Cooperate in Leukemia Development and Modulate the Response to Inflammation
  • DOI:
    10.1182/blood-2024-202521
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Pablo Sanchez Vela;Brianna Kelly;Claudia Brady;Jonathan Foox;Jacob Glass;Ross L Levine;Alan Shih
  • 通讯作者:
    Alan Shih
A Phase 1b Multi-Center Study of the FLT3 Inhibitor Gilteritinib in Combination with the IDH1 Inhibitor Ivosidenib or the IDH2 Inhibitor Enasidenib for Patients with Relapsed or Refractory Acute Myeloid Leukemia Who Have Co-Occurring FLT3/IDH1 or FLT3/IDH2 Mutations
  • DOI:
    10.1182/blood-2023-190801
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Eytan M. Stein;Andriy Derkach;Gabrielle Melamed;Alana Block;Janet Kim;Gergana Georgieva;Vanessa Thompson;Ross L Levine;Andrew M. Intlekofer;Omar Abdel-Wahab;Martin S. Tallman
  • 通讯作者:
    Martin S. Tallman

Ross L Levine的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ross L Levine', 18)}}的其他基金

Assessing the Interplay Between Inflammatory Signaling and Epigenetic Dysregulation in Age-associated Clonal Hematopoiesis and Leukemia Initiation
评估炎症信号传导与表观遗传失调在年龄相关克隆造血和白血病起始中的相互作用
  • 批准号:
    10291637
  • 财政年份:
    2021
  • 资助金额:
    $ 106.2万
  • 项目类别:
Assessing the Interplay Between Inflammatory Signaling and Epigenetic Dysregulation in Age-associated Clonal Hematopoiesis and Leukemia Initiation
评估炎症信号传导与表观遗传失调在年龄相关克隆造血和白血病起始中的相互作用
  • 批准号:
    10659254
  • 财政年份:
    2021
  • 资助金额:
    $ 106.2万
  • 项目类别:
Assessing the Interplay Between Inflammatory Signaling and Epigenetic Dysregulation in Age-associated Clonal Hematopoiesis and Leukemia Initiation
评估炎症信号传导与表观遗传失调在年龄相关克隆造血和白血病起始中的相互作用
  • 批准号:
    10488271
  • 财政年份:
    2021
  • 资助金额:
    $ 106.2万
  • 项目类别:
Developmental Research Program
发展研究计划
  • 批准号:
    10474305
  • 财政年份:
    2021
  • 资助金额:
    $ 106.2万
  • 项目类别:
Project 1: Increasing therapeutic efficacy in isocitrate dehydrongenase (IDH)–mutant acute myeloid leukemia (AML)
项目1:提高异柠檬酸脱氢酶(IDH)突变型急性髓系白血病(AML)的治疗效果
  • 批准号:
    10474275
  • 财政年份:
    2021
  • 资助金额:
    $ 106.2万
  • 项目类别:
Synergistic role of signaling and epigenetics in leukemic transformation
信号传导和表观遗传学在白血病转化中的协同作用
  • 批准号:
    10323022
  • 财政年份:
    2017
  • 资助金额:
    $ 106.2万
  • 项目类别:
Synergistic role of signaling and epigenetics in leukemic transformation
信号传导和表观遗传学在白血病转化中的协同作用
  • 批准号:
    10543794
  • 财政年份:
    2017
  • 资助金额:
    $ 106.2万
  • 项目类别:
Synergistic role of signaling and epigenetics in leukemic transformation
信号传导和表观遗传学在白血病转化中的协同作用
  • 批准号:
    10078940
  • 财政年份:
    2017
  • 资助金额:
    $ 106.2万
  • 项目类别:
ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER
ECOG-ACRIN 综合白血病转化研究中心
  • 批准号:
    9235262
  • 财政年份:
    2014
  • 资助金额:
    $ 106.2万
  • 项目类别:
ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER
ECOG-ACRIN 综合白血病转化研究中心
  • 批准号:
    8605643
  • 财政年份:
    2014
  • 资助金额:
    $ 106.2万
  • 项目类别:

相似海外基金

Arginine Metabolism and Cell Compartmentation
精氨酸代谢和细胞区室
  • 批准号:
    8201567
  • 财政年份:
    1982
  • 资助金额:
    $ 106.2万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了